These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 20861293

  • 1. Simvastatin in the treatment of asthma: lack of steroid-sparing effect.
    Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR.
    Thorax; 2010 Oct; 65(10):891-6. PubMed ID: 20861293
    [Abstract] [Full Text] [Related]

  • 2. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
    Bateman ED, Bleecker ER, Lötvall J, Woodcock A, Forth R, Medley H, Davis AM, Jacques L, Haumann B, Busse WW.
    Respir Med; 2012 May; 106(5):642-50. PubMed ID: 22342538
    [Abstract] [Full Text] [Related]

  • 3. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
    Rice-McDonald G, Bowler S, Staines G, Mitchell C.
    Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
    [Abstract] [Full Text] [Related]

  • 4. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 5. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T, Haggart K, Lee DK, Lipworth BJ.
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [Abstract] [Full Text] [Related]

  • 6. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L, Pizzichini E, Lemière C, Man SF, Cartier A, Hargreave FE, Pizzichini MM.
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [Abstract] [Full Text] [Related]

  • 7. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma.
    Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ.
    J Allergy Clin Immunol; 2007 Feb; 119(2):328-35. PubMed ID: 17141851
    [Abstract] [Full Text] [Related]

  • 8. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 9. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP, Turcotte H, Prince P, Lemière C, Olivenstein R, Laprise C, Larivée P, Bégin P, Laviolette M.
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [Abstract] [Full Text] [Related]

  • 10. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
    Hoffmann HJ, Nielsen LP, Harving H, Heinig JH, Dahl R.
    Clin Respir J; 2008 Jul; 2(3):149-57. PubMed ID: 20298323
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
    [Abstract] [Full Text] [Related]

  • 12. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [Abstract] [Full Text] [Related]

  • 13. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ.
    J Asthma; 1996 Mar; 33(4):265-74. PubMed ID: 8707781
    [Abstract] [Full Text] [Related]

  • 14. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma.
    Nimmagadda SR, Spahn JD, Nelson HS, Jenkins J, Szefler SJ, Leung DY.
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):35-40. PubMed ID: 9690571
    [Abstract] [Full Text] [Related]

  • 15. Effects of steroid therapy on inflammatory cell subtypes in asthma.
    Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR.
    Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
    [Abstract] [Full Text] [Related]

  • 16. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
    Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC.
    Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
    [Abstract] [Full Text] [Related]

  • 17. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

  • 19. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW, Sun YC, Zhou QT, Gai XY, Cao WL, Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.